ICON’s Martin Lachs and Brandon Fletcher provide expert commentary on Adoptive Cell Transfer (ACT) clinical trials in this July 2019 DDN News article.
Read ArticleRelated Information
Media Article
Cell and Gene Therapies: On Course for Commercial Success?
Media Article
Biomarkers in Oncology
Blog
Immuno-oncology: Am I Choosing the Right Biomarker?
Media Article
Oncology Clinical Trials in APAC
Blog
Oncology Clinical Trials in Asia Pacific
Blog
Smart Bioanalytical Strategies in Immuno-Oncology Trials
Blog